Which MRI dye gives the best picture of heart damage?
NCT ID NCT03057561
First seen Apr 26, 2026 · Last updated Jun 23, 2026 · Updated 10 times
Summary
This study compared two contrast agents (Dotarem and Gadovist) used in cardiac MRI to see which provides clearer images of heart muscle damage. 120 adults with coronary artery disease or cardiomyopathy received one of the two dyes during their scan. Researchers rated image quality and tracked heart-related outcomes over time to see if one agent was better at linking scan findings to real-world health events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Gadolinium-based contrast agents (Dotarem and Gadovist)
What this could lead to
If one contrast agent proves superior, it could improve heart MRI accuracy and help doctors better predict heart-related events.
What could go wrong
This is a small pilot study (120 people) comparing two already-approved agents, so major breakthroughs are unlikely. Results may not change current practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.